Securities code: Shandong Buchang Pharmaceuticals Co.Ltd(603858) securities abbreviation: Shandong Buchang Pharmaceuticals Co.Ltd(603858) Announcement No.: 2022080 Shandong Buchang Pharmaceuticals Co.Ltd(603858)
Announcement on holding 2021 annual performance presentation meeting
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and completeness of its contents. Important content tips:
Meeting time: 11:00-12:00 a.m. on Tuesday, May 31, 2022
Venue of the meeting: Shanghai Stock Exchange Shanghai Securities roadshow Center (website:
http://roadshow.sseinfo.com./ ）Meeting mode: online interaction of Shanghai Securities roadshow Center
Investors can log in to the home page of the website of Shanghai Securities roadshow center from Tuesday, May 24 to Monday, May 30, 2022 before 16:00, click on the column of “pre collection of questions” or through the company’s email
（ [email protected]. ）Ask questions. The company will answer the questions generally concerned by investors at the briefing.
Shandong Buchang Pharmaceuticals Co.Ltd(603858) (hereinafter referred to as “the company”) has released the company’s 2021 annual report on April 28, 2022. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company’s 2021 operating results and financial situation, the company plans to hold a 2021 annual performance briefing from 11:00 to 12:00 on May 31, 2022 to exchange issues of concern to investors.
1、 Description meeting type
The investor briefing will be held in the form of online interaction. The company will conduct interactive communication and communication with investors according to the specific conditions of operating results and financial indicators in 2021, and answer the questions generally concerned by investors within the scope of information disclosure.
2、 Explain the time and place of the meeting
(I) meeting time: 11:00-12:00 am, May 31, 2022
(II) venue of the meeting: Shanghai Stock Exchange Shanghai Securities roadshow Center
(website: http://roadshow.sseinfo.com./ ）
(III) meeting mode: online interaction of Shanghai Securities roadshow Center
3、 Participants
Chairman: Mr. Zhao Tao
President: Mr. Zhao Chao
Secretary of the board of directors: Mr. Pu Xiaoping
Chief financial officer: Mr. Wang Baocai
Independent director: Mr. Chi Deqiang
4、 Investor participation mode
(I) investors can log in to the Shanghai Securities roadshow center through the Internet from 11:00 a.m. to 12:00 a.m. on Tuesday, May 31, 2022（ http://roadshow.sseinfo.com./ ）, participate in this performance presentation online, and the company will answer the questions of investors in time.
(II) investors can log in to the homepage of the website of Shanghai Securities roadshow center from Tuesday, May 24 to Monday, May 30, 2022 before 16:00, and click on the column of “pre collection of questions”（ http://roadshow.sseinfo.com./questionCollection.do ）, according to the activity time, select this activity or through the company email（ [email protected]. ）The company will answer questions of general concern to investors at the meeting.
5、 Contact person and consultation method
Contact: Liu Yibo
Tel: 15389675413
Fax: 05305299286
Email: [email protected].
6、 Other matters
After the investor briefing meeting is held, investors can go through the Shanghai Securities roadshow center（ http://roadshow.sseinfo.com./ ）Check the convening and main contents of this investor briefing.
It is hereby announced.
Shandong Buchang Pharmaceuticals Co.Ltd(603858) board of directors may 23, 2022
